Biotech Executive Conversation between Vivacelle Bio's CEO, Harven DeShield, Ph.D., JD and Mr. Berthran Ugeh, partner of a Hedge Fund and CEO of Tendy LLC.
Vivacelle Bio, Incorporated is thrilled to be a @forty3north semifinalist and to move on to the next round of the $5M startup competition! This year, over 500 startups from across North America submitted applications to 43North to complete for $5 million in cash awards! Vivacelle Bio, Incorporated is proud to be among the 134 semifinalists chosen.
Copyright © 2023 Vivacelle Bio Inc. - All Rights Reserved.
Powered by GoDaddy Website Builder
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.